March 2 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* Aurina receives FDA fast track designation for Voclosporin for the treatment
of lupus nephritis
* Expects to analyse,review aura data with FDA later in 2016 to reach agreement
on further clinical development requirements
* Source text for Eikon ID:nBwblY115a
* Further company coverage AUP.TO